Search

everythinglearnresearchcommunity

for

Search:↓

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Treatments for hair loss vary, but cell-based options may be the future.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

Dutasteride is approved to help manage prostate enlargement.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Tattoo machine-assisted drug delivery may improve hair growth in androgenetic alopecia.

Medical aesthetics now helps treat medical conditions, expanding options for dermatologists.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

ASC-CM is more effective than EV for treating osteoarthritis.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Ginsenoside Rb1 may help remodel hypertrophic scars effectively at a dose of 0.56 mg.

Udenafil may help hair grow by activating certain stem cells.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Understanding biological mediators in skin healing can improve treatments for skin wounds.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

More people are seeing dermatologists for hair and scalp problems now than in the past.

Ruxolitinib can cause a delayed skin reaction on the nose.

Treating fat stem cells with low oxygen boosts hair growth cell growth through specific signaling pathways.